ETFs with MiNK Therapeutics (INKT) Exposure

The following ETFs maintain exposure to MiNK Therapeutics (INKT). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

3 ETFs Hold MiNK Therapeutics (INKT)

ETFs holding INKT
Symbol	ETF Name	AUM	Expense Ratio	% Weight in ETF	Market Value	% Weight in INKT
IWC	iShares Micro-Cap ETF	$1.26B	0.60%	<0.01%	$65.40K	0.12%
VXF	Vanguard Extended Market ETF	$30.86B	0.05%	<0.01%	$193.04K	0.30%
VTI	Vanguard Total Stock Market ETF	$701.51B	0.03%	<0.01%	$666.03K	1.04%

ETFs holding INKT
Symbol	% Weight in ETF	ETF Name	AUM	Expense Ratio	Market Value	% Weight in INKT
IWC	<0.01%	iShares Micro-Cap ETF	$1.26B	0.60%	$65.40K	0.12%
VXF	<0.01%	Vanguard Extended Market ETF	$30.86B	0.05%	$193.04K	0.30%
VTI	<0.01%	Vanguard Total Stock Market ETF	$701.51B	0.03%	$666.03K	1.04%

Find ETFs with the TipRanks ETF screener

Popular ETF Comparisons

Compare ETFs >

Popular ETFs

Popular ETFs
Company	Price & Change	Follow
SPYSPDR S&P 500 ETF Trust	―
QQQInvesco QQQ Trust	―
DIASPDR Dow Jones Industrial Average ETF Trust	―
IWMiShares Russell 2000 ETF	―
VOOVanguard S&P 500 ETF	―

Go to My Watchlist >

INKT ETF Exposure FAQ

What ETFs hold MiNK Therapeutics stock?

MiNK Therapeutics (INKT) is currently held by 3 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to INKT include Vanguard (VTI), Vanguard (VXF) and iShares (IWC).

Which ETF has the largest exposure to INKT?

The ETF with the largest exposure to INKT is Vanguard (VTI), with approximately $666.03K in market value exposure.

How much INKT stock is held by ETFs?

ETFs currently hold approximately $924.47K worth of MiNK Therapeutics (INKT) stock, based on TipRanks’ ETF exposure data.

How often is ETF exposure data updated?

ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.

MiNK Therapeutics etf exposure